JP2007524698A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007524698A5 JP2007524698A5 JP2007500219A JP2007500219A JP2007524698A5 JP 2007524698 A5 JP2007524698 A5 JP 2007524698A5 JP 2007500219 A JP2007500219 A JP 2007500219A JP 2007500219 A JP2007500219 A JP 2007500219A JP 2007524698 A5 JP2007524698 A5 JP 2007524698A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical formulation
- pharmaceutically acceptable
- glycopyrronium
- formulation according
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 18
- ANGKOCUUWGHLCE-HKUYNNGSSA-N [(3s)-1,1-dimethylpyrrolidin-1-ium-3-yl] (2r)-2-cyclopentyl-2-hydroxy-2-phenylacetate Chemical compound C1[N+](C)(C)CC[C@@H]1OC(=O)[C@](O)(C=1C=CC=CC=1)C1CCCC1 ANGKOCUUWGHLCE-HKUYNNGSSA-N 0.000 claims 11
- 229960002462 glycopyrronium bromide Drugs 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 11
- SYTBZMRGLBWNTM-SNVBAGLBSA-N (R)-flurbiprofen Chemical compound FC1=CC([C@H](C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-SNVBAGLBSA-N 0.000 claims 7
- -1 cyclohexylmethylene Chemical group 0.000 claims 7
- 208000006673 asthma Diseases 0.000 claims 6
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 claims 5
- 229960003728 ciclesonide Drugs 0.000 claims 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims 5
- 206010039083 rhinitis Diseases 0.000 claims 4
- QIEPWCSVQYUPIY-LEKSSAKUSA-N Delta(1)-progesterone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 QIEPWCSVQYUPIY-LEKSSAKUSA-N 0.000 claims 3
- 206010003557 Asthma exercise induced Diseases 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 2
- 208000000059 Dyspnea Diseases 0.000 claims 2
- 206010013975 Dyspnoeas Diseases 0.000 claims 2
- 206010014561 Emphysema Diseases 0.000 claims 2
- 208000004657 Exercise-Induced Asthma Diseases 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 206010057190 Respiratory tract infections Diseases 0.000 claims 2
- 206010039085 Rhinitis allergic Diseases 0.000 claims 2
- 206010047924 Wheezing Diseases 0.000 claims 2
- 201000010105 allergic rhinitis Diseases 0.000 claims 2
- 206010006451 bronchitis Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000003246 corticosteroid Substances 0.000 claims 2
- 208000024695 exercise-induced bronchoconstriction Diseases 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 208000013220 shortness of breath Diseases 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 208000011479 upper respiratory tract disease Diseases 0.000 claims 2
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical group O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 claims 1
- 230000001078 anti-cholinergic effect Effects 0.000 claims 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 claims 1
- 125000000837 carbohydrate group Chemical group 0.000 claims 1
- 239000000812 cholinergic antagonist Substances 0.000 claims 1
- 229960001334 corticosteroids Drugs 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 229960001021 lactose monohydrate Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04004473 | 2004-02-27 | ||
| PCT/EP2005/050799 WO2005082413A2 (en) | 2004-02-27 | 2005-02-25 | Ciclesonide and glycopyrronium combination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007524698A JP2007524698A (ja) | 2007-08-30 |
| JP2007524698A5 true JP2007524698A5 (https=) | 2008-04-03 |
Family
ID=34895964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007500219A Withdrawn JP2007524698A (ja) | 2004-02-27 | 2005-02-25 | シクレソニドとグリコピロニウムとの組合せ物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20070185067A1 (https=) |
| EP (1) | EP1720577A2 (https=) |
| JP (1) | JP2007524698A (https=) |
| WO (1) | WO2005082413A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1713473B1 (en) | 2004-02-06 | 2013-03-13 | MEDA Pharma GmbH & Co. KG | The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd |
| GB0411056D0 (en) * | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
| GB0523655D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| NZ591969A (en) * | 2005-12-21 | 2012-05-25 | Meda Pharma Gmbh & Co Kg | Combination of anticholinergics, glucocorticoids, beta2-adrenoceptor agonists, PDE 4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
| EP2022796A1 (en) * | 2007-08-07 | 2009-02-11 | Nycomed GmbH | Amorphous ciclesonide |
| ES2528957T3 (es) * | 2010-06-14 | 2015-02-13 | Chiesi Farmaceutici S.P.A. | Forma cristalina del cloruro de glicopirronio |
| EP3473615B1 (en) | 2013-02-28 | 2022-01-19 | Journey Medical Corporation | Glycopyrrolate salts |
| US8558008B2 (en) | 2013-02-28 | 2013-10-15 | Dermira, Inc. | Crystalline glycopyrrolate tosylate |
| US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
| WO2019060595A1 (en) * | 2017-09-20 | 2019-03-28 | Teva Branded Pharmaceutical Products R&D, Inc. | INHALABLE DRY POWDER MEDICINAL PRODUCT COMPRISING GLYCOPYRRONIUM |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US6613795B2 (en) * | 1996-11-11 | 2003-09-02 | Christian Noe | Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments |
| CN1150890C (zh) * | 1998-08-04 | 2004-05-26 | 杰格研究股份公司 | 药用气溶胶制剂 |
| AU756852B2 (en) * | 1998-11-13 | 2003-01-23 | Jagotec Ag | Dry powder for inhalation |
| GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
| DE10062712A1 (de) * | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
| US20030055026A1 (en) * | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| AU2004271744B2 (en) * | 2003-09-16 | 2010-07-29 | Covis Pharma B.V. | Use of ciclesonide for the treatment of respiratory diseases |
-
2005
- 2005-02-25 WO PCT/EP2005/050799 patent/WO2005082413A2/en not_active Ceased
- 2005-02-25 EP EP05708057A patent/EP1720577A2/en not_active Withdrawn
- 2005-02-25 JP JP2007500219A patent/JP2007524698A/ja not_active Withdrawn
- 2005-02-25 US US10/589,871 patent/US20070185067A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004500433A (ja) | チオトロピウムとブデソニドを含む組合せ医薬 | |
| US20070020190A1 (en) | Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients | |
| IL271132B1 (en) | Dry powder aclidinium salt pharmaceutical composition for treatment of copd | |
| CA2496699A1 (en) | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids | |
| US20100329996A1 (en) | Novel Combination of Therapeutic Agents | |
| CA2569077A1 (en) | Combinations comprising antimuscarinic agents and corticosteroids | |
| JP2013542940A5 (https=) | ||
| PT2506844T (pt) | Combinações de um antagonista do recetor muscarínico e um agonista do adrenorrecetor beta-2 | |
| JP2004538241A (ja) | チオトロピウムとプロピオン酸フルチカゾンを含む組合せ医薬 | |
| JP2004500435A (ja) | チオトロピウムとモメタゾンを含む組合せ医薬 | |
| US8258124B2 (en) | Combination medicament | |
| CA2568571A1 (en) | Combinations comprising antimuscarinic agents and corticosteroids | |
| JP2007524698A5 (https=) | ||
| AU2015261103A1 (en) | Combinations of tiotropium bromide, formoterol and budesonide for the treatment of COPD | |
| EP3157522A1 (en) | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses | |
| EP2080523A1 (en) | Compositions comprising an antimuscarinic and a long-acting beta-agonist | |
| JP2007505829A5 (https=) | ||
| US20140179651A1 (en) | Ciclesonide for the treatment of airway disease in horses | |
| CA2538419A1 (en) | Use of ciclesonide for the treatment of respiratory diseases | |
| US20070185067A1 (en) | Ciclesonide and glycopyrronium combination | |
| JP2004500434A (ja) | サルメテロールとブデソニドを含む組合せ医薬 | |
| JP2007524699A5 (https=) | ||
| WO2018006001A1 (en) | Compositions and methods for treatment of copd | |
| WO2007046113A3 (en) | Novel pharmaceutical composition comprising alkaloid and process thereof | |
| JP2007533706A5 (https=) |